Juli Miller

Juli Miller is a seasoned professional with a strong background in investor relations and medical writing.

Currently serving as the Senior Director of Investor Relations at Adaptimmune in Philadelphia, PA.

Previously held key roles as a Lead Medical Writer for prominent companies like Jazz, Shire, and ViroPharma.

Earned a Doctor of Philosophy (PhD) in Immunology from the University of Pennsylvania in 2005.

Completed studies in Biology, Anthropology, and English for her Bachelor's degree at Bryn Mawr College.

Her education also includes a Master's degree in Immunology from Imperial Cancer Research Fund.

Throughout her career, Juli has demonstrated expertise in the pharmaceutical industry and academia, showcasing a diverse skill set.

Her professional journey includes positions such as Associate Director at Jazz Pharmaceuticals, Manager at Shire, and Lab Manager at the University of Pennsylvania.

Juli's experience also extends to roles like Senior Medical Writer at ViroPharma Incorporated and Medical Writer at Synchrogenix, a Certara company.

With a solid educational foundation and a wealth of experience in various organizations, Juli Miller stands out as a versatile and accomplished professional.

Her dedication to the field of immunology and her contributions to investor relations and medical writing highlight her as a valuable asset in the industry.